Skip to main content

Table 4 Concurrence of two study response criteria (n = 30)

From: Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support

 

Criterion 2

yes

no

Criterion 1

yes

12 (40%)

3 (10%)

no

0 (0%)

15 (50%)

  1. Criterion 1 = ≥ 50% improvement from pre-treatment BSS at end of 4-week post-ketamine follow-up phase
  2. Criterion 2 = BSS ≤ 6 at end of 4-week post-ketamine follow-up phase; 2 participants lost to follow-up